12-47846052-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000376.3(VDR):​c.1024+283G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.348 in 152,108 control chromosomes in the GnomAD database, including 9,698 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.35 ( 9698 hom., cov: 32)

Consequence

VDR
NM_000376.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter P:1B:2

Conservation

PhyloP100: -0.0330

Publications

1136 publications found
Variant links:
Genes affected
VDR (HGNC:12679): (vitamin D receptor) This gene encodes vitamin D3 receptor, which is a member of the nuclear hormone receptor superfamily of ligand-inducible transcription factors. This receptor also functions as a receptor for the secondary bile acid, lithocholic acid. Downstream targets of vitamin D3 receptor are principally involved in mineral metabolism, though this receptor regulates a variety of other metabolic pathways, such as those involved in immune response and cancer. Mutations in this gene are associated with type II vitamin D-resistant rickets. A single nucleotide polymorphism in the initiation codon results in an alternate translation start site three codons downstream. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study provided evidence for translational readthrough in this gene, and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon. [provided by RefSeq, Jun 2018]
VDR Gene-Disease associations (from GenCC):
  • vitamin D-dependent rickets, type 2A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • vitamin D-dependent rickets, type 2
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 12-47846052-C-T is Benign according to our data. Variant chr12-47846052-C-T is described in ClinVar as Benign. ClinVar VariationId is 1259287.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.43 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VDRNM_000376.3 linkc.1024+283G>A intron_variant Intron 9 of 9 ENST00000549336.6 NP_000367.1 P11473-1F1D8P8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VDRENST00000549336.6 linkc.1024+283G>A intron_variant Intron 9 of 9 1 NM_000376.3 ENSP00000449573.2 P11473-1

Frequencies

GnomAD3 genomes
AF:
0.349
AC:
52971
AN:
151990
Hom.:
9691
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.303
Gnomad AMI
AF:
0.280
Gnomad AMR
AF:
0.306
Gnomad ASJ
AF:
0.362
Gnomad EAS
AF:
0.0636
Gnomad SAS
AF:
0.446
Gnomad FIN
AF:
0.332
Gnomad MID
AF:
0.357
Gnomad NFE
AF:
0.403
Gnomad OTH
AF:
0.367
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.348
AC:
53009
AN:
152108
Hom.:
9698
Cov.:
32
AF XY:
0.346
AC XY:
25737
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.303
AC:
12552
AN:
41480
American (AMR)
AF:
0.306
AC:
4678
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.362
AC:
1256
AN:
3468
East Asian (EAS)
AF:
0.0639
AC:
331
AN:
5178
South Asian (SAS)
AF:
0.446
AC:
2150
AN:
4826
European-Finnish (FIN)
AF:
0.332
AC:
3513
AN:
10566
Middle Eastern (MID)
AF:
0.363
AC:
106
AN:
292
European-Non Finnish (NFE)
AF:
0.403
AC:
27385
AN:
67990
Other (OTH)
AF:
0.371
AC:
784
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1790
3580
5370
7160
8950
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
526
1052
1578
2104
2630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.381
Hom.:
41027
Bravo
AF:
0.338
Asia WGS
AF:
0.279
AC:
969
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hepatocellular carcinoma Pathogenic:1
Jul 14, 2022
Bioengineering and Technology, Gauhati University
Significance:Likely risk allele
Review Status:no assertion criteria provided
Collection Method:case-control

- -

not provided Benign:1
Mar 29, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Periodontitis Benign:1
Apr 20, 2023
Genetics Laboratory, Lanzhou University
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:case-control

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
3.8
DANN
Benign
0.54
PhyloP100
-0.033
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1544410; hg19: chr12-48239835; API